US20080004218A1 - Methods for enhanced epithelial permeation of y2 receptor-binding peptides for treating and preventing obesity - Google Patents

Methods for enhanced epithelial permeation of y2 receptor-binding peptides for treating and preventing obesity Download PDF

Info

Publication number
US20080004218A1
US20080004218A1 US11/563,587 US56358706A US2008004218A1 US 20080004218 A1 US20080004218 A1 US 20080004218A1 US 56358706 A US56358706 A US 56358706A US 2008004218 A1 US2008004218 A1 US 2008004218A1
Authority
US
United States
Prior art keywords
pyy
formulation
y2 receptor
ml
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/563,587
Inventor
Steven Quay
Gordon Brandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
Marina Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/322,266 priority Critical patent/US7166575B2/en
Priority to US49322603P priority
Priority to US50117003P priority
Priority to US51078503P priority
Priority to US51729003P priority
Priority to US51881203P priority
Priority to US10/745,069 priority patent/US7186691B2/en
Priority to US10/869,649 priority patent/US7186692B2/en
Application filed by Marina Biotech Inc filed Critical Marina Biotech Inc
Priority to US11/563,587 priority patent/US20080004218A1/en
Publication of US20080004218A1 publication Critical patent/US20080004218A1/en
Application status is Abandoned legal-status Critical

Links